Search

Search Constraints

You searched for: Author/Creator Pella, P.

Search Results

1. Brodalumab for the treatment of moderate‐to‐severe plaque‐type psoriasis: a real‐life, retrospective 24‐week experience. (13th October 2020)

2. Risankizumab shows faster response in bio naïve than in bio‐experienced psoriatic patients. (22nd June 2022)